Scientific Reports-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：心理学 经验分享：2023年5月说通过了初审，然后接下来三个月一直没找到审稿人，发邮件无回复，2024年1月退稿。前后8个月，很无语，不多说了，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肝硬化;门脉高压 经验分享：2023年8月投稿，2024年1月给了1个审稿人意见，返修再投，2024年3月拒稿。一共历时7个月。2024年1月的审稿人，和2024年3月的审稿人不是一个人，对文章的观点完全不一样，白白浪费时间。找不到合适的审稿人是关键问题，不是相关领域的专家都搞不清文章在讲什么。审稿太慢，是一个问题，发邮件催促没有意义。前后是不同的审稿人，太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：数据分析 经验分享：用了一年多时间，太不容易了，分享一下过程吧 Publishing and rights Submission status Date Submission is in publishing and rights 18 Mar 2024 Peer review Submission status Date Submission accepted 18 Mar 2024 Submission under peer review 25 Feb 2024 Submission passed technical check 25 Feb 2024 Amendment received 24 Feb 2024 Revision received 23 Feb 2024 Submission under peer review 21 Feb 2023 Technical check Submission status Date Submission passed technical check 21 Feb 2023 Submission is under technical check 20 Feb 2023 Submission received Submission status Date Submission received 20 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们，现在版面费是第三方收取么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182530, encodeId=53c4218253026, content=偏重的研究方向：临床预测模型 经验分享：Submission under peer review 14 Dec 2023 Submission passed technical check 14 Dec 2023 Amendment received 14 Dec 2023 Amendment received 07 Dec 2023 Amendment received 07 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023 Submission under peer review一直没有变化，是不是连审稿人都没邀请啊？不会被忘了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa979032293, createdName=ms2000000264173426, createdTime=Fri Jan 19 00:15:20 CST 2024, time=2024-01-19, status=1, ipAttribution=新疆)]

2023-12-06 发大文章带我一个二十作吧来自上海

想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.

52 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：心理学 经验分享：2023年5月说通过了初审，然后接下来三个月一直没找到审稿人，发邮件无回复，2024年1月退稿。前后8个月，很无语，不多说了，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肝硬化;门脉高压 经验分享：2023年8月投稿，2024年1月给了1个审稿人意见，返修再投，2024年3月拒稿。一共历时7个月。2024年1月的审稿人，和2024年3月的审稿人不是一个人，对文章的观点完全不一样，白白浪费时间。找不到合适的审稿人是关键问题，不是相关领域的专家都搞不清文章在讲什么。审稿太慢，是一个问题，发邮件催促没有意义。前后是不同的审稿人，太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：数据分析 经验分享：用了一年多时间，太不容易了，分享一下过程吧 Publishing and rights Submission status Date Submission is in publishing and rights 18 Mar 2024 Peer review Submission status Date Submission accepted 18 Mar 2024 Submission under peer review 25 Feb 2024 Submission passed technical check 25 Feb 2024 Amendment received 24 Feb 2024 Revision received 23 Feb 2024 Submission under peer review 21 Feb 2023 Technical check Submission status Date Submission passed technical check 21 Feb 2023 Submission is under technical check 20 Feb 2023 Submission received Submission status Date Submission received 20 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们，现在版面费是第三方收取么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182530, encodeId=53c4218253026, content=偏重的研究方向：临床预测模型 经验分享：Submission under peer review 14 Dec 2023 Submission passed technical check 14 Dec 2023 Amendment received 14 Dec 2023 Amendment received 07 Dec 2023 Amendment received 07 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023 Submission under peer review一直没有变化，是不是连审稿人都没邀请啊？不会被忘了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa979032293, createdName=ms2000000264173426, createdTime=Fri Jan 19 00:15:20 CST 2024, time=2024-01-19, status=1, ipAttribution=新疆)]

2023-07-28 ms5000000683483699 来自山东省

偏重的研究方向：生物信息学;肿瘤
经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了

59 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：心理学 经验分享：2023年5月说通过了初审，然后接下来三个月一直没找到审稿人，发邮件无回复，2024年1月退稿。前后8个月，很无语，不多说了，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肝硬化;门脉高压 经验分享：2023年8月投稿，2024年1月给了1个审稿人意见，返修再投，2024年3月拒稿。一共历时7个月。2024年1月的审稿人，和2024年3月的审稿人不是一个人，对文章的观点完全不一样，白白浪费时间。找不到合适的审稿人是关键问题，不是相关领域的专家都搞不清文章在讲什么。审稿太慢，是一个问题，发邮件催促没有意义。前后是不同的审稿人，太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：数据分析 经验分享：用了一年多时间，太不容易了，分享一下过程吧 Publishing and rights Submission status Date Submission is in publishing and rights 18 Mar 2024 Peer review Submission status Date Submission accepted 18 Mar 2024 Submission under peer review 25 Feb 2024 Submission passed technical check 25 Feb 2024 Amendment received 24 Feb 2024 Revision received 23 Feb 2024 Submission under peer review 21 Feb 2023 Technical check Submission status Date Submission passed technical check 21 Feb 2023 Submission is under technical check 20 Feb 2023 Submission received Submission status Date Submission received 20 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们，现在版面费是第三方收取么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182530, encodeId=53c4218253026, content=偏重的研究方向：临床预测模型 经验分享：Submission under peer review 14 Dec 2023 Submission passed technical check 14 Dec 2023 Amendment received 14 Dec 2023 Amendment received 07 Dec 2023 Amendment received 07 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023 Submission under peer review一直没有变化，是不是连审稿人都没邀请啊？不会被忘了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa979032293, createdName=ms2000000264173426, createdTime=Fri Jan 19 00:15:20 CST 2024, time=2024-01-19, status=1, ipAttribution=新疆)]

2024-03-28 萝布来自湖北省

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：基础
经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。

13 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：心理学 经验分享：2023年5月说通过了初审，然后接下来三个月一直没找到审稿人，发邮件无回复，2024年1月退稿。前后8个月，很无语，不多说了，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肝硬化;门脉高压 经验分享：2023年8月投稿，2024年1月给了1个审稿人意见，返修再投，2024年3月拒稿。一共历时7个月。2024年1月的审稿人，和2024年3月的审稿人不是一个人，对文章的观点完全不一样，白白浪费时间。找不到合适的审稿人是关键问题，不是相关领域的专家都搞不清文章在讲什么。审稿太慢，是一个问题，发邮件催促没有意义。前后是不同的审稿人，太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：数据分析 经验分享：用了一年多时间，太不容易了，分享一下过程吧 Publishing and rights Submission status Date Submission is in publishing and rights 18 Mar 2024 Peer review Submission status Date Submission accepted 18 Mar 2024 Submission under peer review 25 Feb 2024 Submission passed technical check 25 Feb 2024 Amendment received 24 Feb 2024 Revision received 23 Feb 2024 Submission under peer review 21 Feb 2023 Technical check Submission status Date Submission passed technical check 21 Feb 2023 Submission is under technical check 20 Feb 2023 Submission received Submission status Date Submission received 20 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们，现在版面费是第三方收取么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182530, encodeId=53c4218253026, content=偏重的研究方向：临床预测模型 经验分享：Submission under peer review 14 Dec 2023 Submission passed technical check 14 Dec 2023 Amendment received 14 Dec 2023 Amendment received 07 Dec 2023 Amendment received 07 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023 Submission under peer review一直没有变化，是不是连审稿人都没邀请啊？不会被忘了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa979032293, createdName=ms2000000264173426, createdTime=Fri Jan 19 00:15:20 CST 2024, time=2024-01-19, status=1, ipAttribution=新疆)]

2024-03-04 ms7957059236203375 来自四川省

偏重的研究方向：肿瘤
经验分享：一月份投，二月份就接收了，有没有想问的！

66 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：心理学 经验分享：2023年5月说通过了初审，然后接下来三个月一直没找到审稿人，发邮件无回复，2024年1月退稿。前后8个月，很无语，不多说了，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肝硬化;门脉高压 经验分享：2023年8月投稿，2024年1月给了1个审稿人意见，返修再投，2024年3月拒稿。一共历时7个月。2024年1月的审稿人，和2024年3月的审稿人不是一个人，对文章的观点完全不一样，白白浪费时间。找不到合适的审稿人是关键问题，不是相关领域的专家都搞不清文章在讲什么。审稿太慢，是一个问题，发邮件催促没有意义。前后是不同的审稿人，太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：数据分析 经验分享：用了一年多时间，太不容易了，分享一下过程吧 Publishing and rights Submission status Date Submission is in publishing and rights 18 Mar 2024 Peer review Submission status Date Submission accepted 18 Mar 2024 Submission under peer review 25 Feb 2024 Submission passed technical check 25 Feb 2024 Amendment received 24 Feb 2024 Revision received 23 Feb 2024 Submission under peer review 21 Feb 2023 Technical check Submission status Date Submission passed technical check 21 Feb 2023 Submission is under technical check 20 Feb 2023 Submission received Submission status Date Submission received 20 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们，现在版面费是第三方收取么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182530, encodeId=53c4218253026, content=偏重的研究方向：临床预测模型 经验分享：Submission under peer review 14 Dec 2023 Submission passed technical check 14 Dec 2023 Amendment received 14 Dec 2023 Amendment received 07 Dec 2023 Amendment received 07 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023 Submission under peer review一直没有变化，是不是连审稿人都没邀请啊？不会被忘了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa979032293, createdName=ms2000000264173426, createdTime=Fri Jan 19 00:15:20 CST 2024, time=2024-01-19, status=1, ipAttribution=新疆)]

2024-03-25 ms2000001772107411 来自广东省

这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了

14 0

[GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：心理学 经验分享：2023年5月说通过了初审，然后接下来三个月一直没找到审稿人，发邮件无回复，2024年1月退稿。前后8个月，很无语，不多说了，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肝硬化;门脉高压 经验分享：2023年8月投稿，2024年1月给了1个审稿人意见，返修再投，2024年3月拒稿。一共历时7个月。2024年1月的审稿人，和2024年3月的审稿人不是一个人，对文章的观点完全不一样，白白浪费时间。找不到合适的审稿人是关键问题，不是相关领域的专家都搞不清文章在讲什么。审稿太慢，是一个问题，发邮件催促没有意义。前后是不同的审稿人，太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：数据分析 经验分享：用了一年多时间，太不容易了，分享一下过程吧 Publishing and rights Submission status Date Submission is in publishing and rights 18 Mar 2024 Peer review Submission status Date Submission accepted 18 Mar 2024 Submission under peer review 25 Feb 2024 Submission passed technical check 25 Feb 2024 Amendment received 24 Feb 2024 Revision received 23 Feb 2024 Submission under peer review 21 Feb 2023 Technical check Submission status Date Submission passed technical check 21 Feb 2023 Submission is under technical check 20 Feb 2023 Submission received Submission status Date Submission received 20 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们，现在版面费是第三方收取么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182530, encodeId=53c4218253026, content=偏重的研究方向：临床预测模型 经验分享：Submission under peer review 14 Dec 2023 Submission passed technical check 14 Dec 2023 Amendment received 14 Dec 2023 Amendment received 07 Dec 2023 Amendment received 07 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023 Submission under peer review一直没有变化，是不是连审稿人都没邀请啊？不会被忘了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa979032293, createdName=ms2000000264173426, createdTime=Fri Jan 19 00:15:20 CST 2024, time=2024-01-19, status=1, ipAttribution=新疆)]

2024-03-25 ms7000000723272542 来自四川省

审稿速度:12.0 | 投稿命中率:25.0
偏重的研究方向：心理学
经验分享：2023年5月说通过了初审，然后接下来三个月一直没找到审稿人，发邮件无回复，2024年1月退稿。前后8个月，很无语，不多说了，慎投！

14 0

[GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：心理学 经验分享：2023年5月说通过了初审，然后接下来三个月一直没找到审稿人，发邮件无回复，2024年1月退稿。前后8个月，很无语，不多说了，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肝硬化;门脉高压 经验分享：2023年8月投稿，2024年1月给了1个审稿人意见，返修再投，2024年3月拒稿。一共历时7个月。2024年1月的审稿人，和2024年3月的审稿人不是一个人，对文章的观点完全不一样，白白浪费时间。找不到合适的审稿人是关键问题，不是相关领域的专家都搞不清文章在讲什么。审稿太慢，是一个问题，发邮件催促没有意义。前后是不同的审稿人，太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：数据分析 经验分享：用了一年多时间，太不容易了，分享一下过程吧 Publishing and rights Submission status Date Submission is in publishing and rights 18 Mar 2024 Peer review Submission status Date Submission accepted 18 Mar 2024 Submission under peer review 25 Feb 2024 Submission passed technical check 25 Feb 2024 Amendment received 24 Feb 2024 Revision received 23 Feb 2024 Submission under peer review 21 Feb 2023 Technical check Submission status Date Submission passed technical check 21 Feb 2023 Submission is under technical check 20 Feb 2023 Submission received Submission status Date Submission received 20 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们，现在版面费是第三方收取么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182530, encodeId=53c4218253026, content=偏重的研究方向：临床预测模型 经验分享：Submission under peer review 14 Dec 2023 Submission passed technical check 14 Dec 2023 Amendment received 14 Dec 2023 Amendment received 07 Dec 2023 Amendment received 07 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023 Submission under peer review一直没有变化，是不是连审稿人都没邀请啊？不会被忘了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa979032293, createdName=ms2000000264173426, createdTime=Fri Jan 19 00:15:20 CST 2024, time=2024-01-19, status=1, ipAttribution=新疆)]

2024-03-22 ms6000001827613117 来自安徽省

审稿速度:12.0 | 投稿命中率:5.0
偏重的研究方向：肝硬化;门脉高压
经验分享：2023年8月投稿，2024年1月给了1个审稿人意见，返修再投，2024年3月拒稿。一共历时7个月。2024年1月的审稿人，和2024年3月的审稿人不是一个人，对文章的观点完全不一样，白白浪费时间。找不到合适的审稿人是关键问题，不是相关领域的专家都搞不清文章在讲什么。审稿太慢，是一个问题，发邮件催促没有意义。前后是不同的审稿人，太可怕。慎投。

15 0

[GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：心理学 经验分享：2023年5月说通过了初审，然后接下来三个月一直没找到审稿人，发邮件无回复，2024年1月退稿。前后8个月，很无语，不多说了，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肝硬化;门脉高压 经验分享：2023年8月投稿，2024年1月给了1个审稿人意见，返修再投，2024年3月拒稿。一共历时7个月。2024年1月的审稿人，和2024年3月的审稿人不是一个人，对文章的观点完全不一样，白白浪费时间。找不到合适的审稿人是关键问题，不是相关领域的专家都搞不清文章在讲什么。审稿太慢，是一个问题，发邮件催促没有意义。前后是不同的审稿人，太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：数据分析 经验分享：用了一年多时间，太不容易了，分享一下过程吧 Publishing and rights Submission status Date Submission is in publishing and rights 18 Mar 2024 Peer review Submission status Date Submission accepted 18 Mar 2024 Submission under peer review 25 Feb 2024 Submission passed technical check 25 Feb 2024 Amendment received 24 Feb 2024 Revision received 23 Feb 2024 Submission under peer review 21 Feb 2023 Technical check Submission status Date Submission passed technical check 21 Feb 2023 Submission is under technical check 20 Feb 2023 Submission received Submission status Date Submission received 20 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们，现在版面费是第三方收取么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182530, encodeId=53c4218253026, content=偏重的研究方向：临床预测模型 经验分享：Submission under peer review 14 Dec 2023 Submission passed technical check 14 Dec 2023 Amendment received 14 Dec 2023 Amendment received 07 Dec 2023 Amendment received 07 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023 Submission under peer review一直没有变化，是不是连审稿人都没邀请啊？不会被忘了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa979032293, createdName=ms2000000264173426, createdTime=Fri Jan 19 00:15:20 CST 2024, time=2024-01-19, status=1, ipAttribution=新疆)]

2024-03-18 SENOMEGA 来自江苏省

审稿速度:24.0 | 投稿命中率:50.0
偏重的研究方向：数据分析
经验分享：用了一年多时间，太不容易了，分享一下过程吧
Publishing and rights
Submission status Date
Submission is in publishing and rights
18 Mar 2024
Peer review
Submission status Date
Submission accepted
18 Mar 2024
Submission under peer review
25 Feb 2024
Submission passed technical check
25 Feb 2024
Amendment received
24 Feb 2024
Revision received
23 Feb 2024
Submission under peer review
21 Feb 2023
Technical check
Submission status Date
Submission passed technical check
21 Feb 2023
Submission is under technical check
20 Feb 2023
Submission received
Submission status Date
Submission received
20 Feb 2023

18 0

[GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：心理学 经验分享：2023年5月说通过了初审，然后接下来三个月一直没找到审稿人，发邮件无回复，2024年1月退稿。前后8个月，很无语，不多说了，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肝硬化;门脉高压 经验分享：2023年8月投稿，2024年1月给了1个审稿人意见，返修再投，2024年3月拒稿。一共历时7个月。2024年1月的审稿人，和2024年3月的审稿人不是一个人，对文章的观点完全不一样，白白浪费时间。找不到合适的审稿人是关键问题，不是相关领域的专家都搞不清文章在讲什么。审稿太慢，是一个问题，发邮件催促没有意义。前后是不同的审稿人，太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：数据分析 经验分享：用了一年多时间，太不容易了，分享一下过程吧 Publishing and rights Submission status Date Submission is in publishing and rights 18 Mar 2024 Peer review Submission status Date Submission accepted 18 Mar 2024 Submission under peer review 25 Feb 2024 Submission passed technical check 25 Feb 2024 Amendment received 24 Feb 2024 Revision received 23 Feb 2024 Submission under peer review 21 Feb 2023 Technical check Submission status Date Submission passed technical check 21 Feb 2023 Submission is under technical check 20 Feb 2023 Submission received Submission status Date Submission received 20 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们，现在版面费是第三方收取么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182530, encodeId=53c4218253026, content=偏重的研究方向：临床预测模型 经验分享：Submission under peer review 14 Dec 2023 Submission passed technical check 14 Dec 2023 Amendment received 14 Dec 2023 Amendment received 07 Dec 2023 Amendment received 07 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023 Submission under peer review一直没有变化，是不是连审稿人都没邀请啊？不会被忘了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa979032293, createdName=ms2000000264173426, createdTime=Fri Jan 19 00:15:20 CST 2024, time=2024-01-19, status=1, ipAttribution=新疆)]

2024-03-13 ms7957059236203375 来自四川省

大佬们，现在版面费是第三方收取么？

18 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：心理学 经验分享：2023年5月说通过了初审，然后接下来三个月一直没找到审稿人，发邮件无回复，2024年1月退稿。前后8个月，很无语，不多说了，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肝硬化;门脉高压 经验分享：2023年8月投稿，2024年1月给了1个审稿人意见，返修再投，2024年3月拒稿。一共历时7个月。2024年1月的审稿人，和2024年3月的审稿人不是一个人，对文章的观点完全不一样，白白浪费时间。找不到合适的审稿人是关键问题，不是相关领域的专家都搞不清文章在讲什么。审稿太慢，是一个问题，发邮件催促没有意义。前后是不同的审稿人，太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：数据分析 经验分享：用了一年多时间，太不容易了，分享一下过程吧 Publishing and rights Submission status Date Submission is in publishing and rights 18 Mar 2024 Peer review Submission status Date Submission accepted 18 Mar 2024 Submission under peer review 25 Feb 2024 Submission passed technical check 25 Feb 2024 Amendment received 24 Feb 2024 Revision received 23 Feb 2024 Submission under peer review 21 Feb 2023 Technical check Submission status Date Submission passed technical check 21 Feb 2023 Submission is under technical check 20 Feb 2023 Submission received Submission status Date Submission received 20 Feb 2023 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们，现在版面费是第三方收取么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2182530, encodeId=53c4218253026, content=偏重的研究方向：临床预测模型 经验分享：Submission under peer review 14 Dec 2023 Submission passed technical check 14 Dec 2023 Amendment received 14 Dec 2023 Amendment received 07 Dec 2023 Amendment received 07 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023 Submission under peer review一直没有变化，是不是连审稿人都没邀请啊？不会被忘了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa979032293, createdName=ms2000000264173426, createdTime=Fri Jan 19 00:15:20 CST 2024, time=2024-01-19, status=1, ipAttribution=新疆)]

2024-01-19 ms2000000264173426 来自新疆

偏重的研究方向：临床预测模型
经验分享：Submission under peer review
14 Dec 2023
Submission passed technical check
14 Dec 2023
Amendment received
14 Dec 2023
Amendment received
07 Dec 2023
Amendment received
07 Dec 2023
Submission is under technical check
04 Dec 2023
Submission received
Submission status Date
Submission received
04 Dec 2023
Submission under peer review一直没有变化，是不是连审稿人都没邀请啊？不会被忘了吧。。。

33 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务